Search clinical trials for: Amlodipine, atorvastatin drug combination

Total 6043 results

Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia (JEWEL I)

Hypertension | Dyslipidemia

Canada, United Kingdom
Shanghai Jiao Tong University School of Medicine

Recruiting

Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

Hypertension | Atrial Fibrillation

China
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Hypertension | Angina Pectoris | Hypercholesterolemia | Familial Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. (JEWEL II)

Hypertension | Hyperlipidemia

Greece, Austria, Finland, Italy, Hungary, Belgium, Spain, Ireland, Portugal, Slovenia, Switzerland
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population (CAPABLE)

Hypertension | Dyslipidemia

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels (GEMINI-AALA)

Hypertension | Hyperlipidemia

Brazil, Turkey, Taiwan, Argentina, India, Philippines, Singapore, Thailand, Australia, Chile, South Africa, Jordan, Korea, Republic of, Lebanon, United Arab Emirates, Malaysia, Peru, Israel, Indonesia, Guatemala, Hong Kong, Kuwait, ... and more
Shanghai Jiao Tong University School of Medicine

Recruiting

Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

Isolated Systolic Hypertension

China
Jeil Pharmaceutical Co., Ltd.

Completed

Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

Hypertension With Hyperlipidemia

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin

Hypertension | Hypercholesterolemia

Japan
Yerevan State Medical University
Servier

Unknown

Effect of Atorvastatin on Carotid Intima Media Thickness

Hypercholesterolemia | Essential Hypertension
Yuhan Corporation

Completed

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia (CORONA)

Hypertension | Dyslipidemias

Korea, Republic of
Midas Pharma GmbH

Completed

Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin

Healthy Volunteers

Jordan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk (TOGETHER)

Hypertension | Dyslipidemia

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors (CRUCIAL)

Hypertension | Hypercholesterolemia

Costa Rica, Korea, Republic of, Panama, Turkey, Croatia, Taiwan, Dominican Republic, Thailand, Mexico, Russian Federation, Lebanon, United Arab Emirates, Malaysia, Philippines, Indonesia, Jordan, Czechia, Kuwait, Saudi Arabia, Venezuel...
Shanghai Institute of Hypertension

Unknown

Amlodipine Plus/Minus Atorvastatin for Protection of Arteries

Arterial and Arteriolar Disorders

China
Wuhan Union Hospital, China

Enrolling by invitation

An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment

Hepatitis B, Chronic | Lipid Disorder

China
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia (HS-25-C-01)

Primary Hypercholesterolemia
Servier Russia

Completed

Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET) (TARGET)

Arterial Hypertension | HTN

Russian Federation
Boehringer Ingelheim

Completed

Open Label Study Telmisartan and Amlodipine in Hypertension

Hypertension

Belgium, Canada, Denmark, Finland, France, Korea, Republic of, Netherlands, Norway, Philippines, South Africa, Sweden, Taiwan
Boehringer Ingelheim

Completed

Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension

Hypertension

Belgium, Canada, Denmark, Finland, France, Korea, Republic of, Netherlands, Norway, Philippines, South Africa, Sweden, Taiwan
Boehringer Ingelheim

Completed

Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension

Hypertension

Australia, Austria, Bulgaria, Czech Republic, Ireland, Italy, New Zealand, Russian Federation, Slovakia, Spain, Switzerland, Turkey, Ukraine, United Kingdom
Boehringer Ingelheim

Completed

Telmisartan and Amlodipine Versus Monocomponent Tablets

Hypertension

Canada
Himayat Ullah
Khyber Medical University Peshawar; Ayub Teaching Hospital

Completed

Atorvastatin as an Antihypertensive Agent

Atorvastatin Antihypertensive Effect

Saudi Arabia
HK inno.N Corporation

Unknown

Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Ahn-Gook Pharmaceuticals Co.,Ltd
Asan Medical Center

Completed

Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301

Hypertension

Korea, Republic of
Dong-A Pharmaceutical Co., Ltd.

Completed

A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

Healthy Male Volunteer
Daewoong Pharmaceutical Co. LTD.

Unknown

Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

Hypertension, Dyslipidemia

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Double Blind Atorvastatin Amlodipine Study (DUAAL)

Angina

Slovakia, Norway, Poland, Croatia, Latvia, Estonia, Turkey, Romania, Hungary, Czechia, South Africa
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia

Hypertension | Hyperlipidemia

China
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition

Healthy

Germany
Boehringer Ingelheim

Completed

Telmisartan, Amlodipine and Combination in Healthy Subjects

Healthy

China
HK inno.N Corporation

Completed

Bioequivalence Study of CJ-30061 in Healthy Male Volunteers

Hypertension | Hyperlipidemia

Korea, Republic of
Boehringer Ingelheim

Completed

Telmisartan+Amlodipine Fixed Dose Combination in Hypertension

Hypertension

China
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition

Healthy

India
Daewoong Pharmaceutical Co. LTD.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. (CKD-345)

Essential Hypertension | Hyperlipidemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension

Hypertension

Korea, Republic of
International Bio service

Not yet recruiting

Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets

Healthy Volunteer
Boehringer Ingelheim

Completed

Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

Healthy
Hotel Dieu de France Hospital
Pfizer; Nouvelle Société Française d'Athérosclérose

Completed

The HDL Particle Protection Study (HDL PROTECT)

Dyslipidemia in Patients With Diabetes Mellitus

Lebanon
Chong Kun Dang Pharmaceutical
Severance Hospital

Completed

Drug-drug Interaction Study(CKD-501, Amlodipine)

Type 2 Diabetes Mellitus

Korea, Republic of
Boehringer Ingelheim

Completed

Filtered Trial for Amlodipine Non-responder

Hypertension

Japan
Boehringer Ingelheim

Completed

Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

Hypertension

United States, Bulgaria, Czech Republic, France, Hungary, Korea, Republic of, Romania, Russian Federation, Slovakia, Spain, Ukraine
Kumamoto University

Completed

Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS)

Coronary Artery Disease | Hypercholesterolemia

Japan
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

Hypertension | Hyperlipidemia

Korea, Republic of
Novartis Pharmaceuticals

Withdrawn

Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension

Hypertension
Boehringer Ingelheim

Withdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Hypertension

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors (EXCEL)

Hypertension and Cardiovascular Risk Factors
Charles University, Czech Republic
Brno University Hospital; University Hospital Olomouc; University Hospital Pilsen and other collaborators

Withdrawn

Fixed Combination for Lipid and Blood Pressure Control (FILIP)

Dyslipidemias | Lipid Metabolism Disorders | Blood Pressure | Arterial Hypertension

Czechia

Search clinical trials for: Amlodipine, atorvastatin drug combination

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations